Diagnostic News and Research

RSS

Celera applies CE mark to real-time PCR test for detection of variant in KIF6 gene

Celera Corporation today announced that it has signed a Declaration of Conformity and applied the CE mark to a real-time PCR (polymerase chain reaction) test for detection of a variant in the KIF6 gene, allowing the test to be marketed in the European Union and other geographic areas that recognize the CE Mark.

7 Jun 2010

SCCT names finalists of fourth annual Young Investigator Award

The Society of Cardiovascular Computed Tomography, the leading international professional society dedicated to research, education and clinical excellence in cardiovascular computed tomography, has named the finalists of the fourth annual Young Investigator Award. Sponsored by Toshiba America Medical Systems, Inc. through an unrestricted educational grant, the Young Investigator Award will be awarded to two residents or fellows in either radiology or cardiology for their patient care research in the categories of technical and clinical advancement of cardiovascular CT.

7 Jun 2010

Thesis examines infections caused by Anaplasma phagocytophilum in lambs

Erik Georg Granquist's thesis examines infections caused by the bacterium Anaplasma phagocytophilum in lambs. This bacterium is the cause of the disease tick-borne fever in ruminants and granulocytic anaplasmosis in humans. The bacterium is transmitted by ticks and is the indirect cause of considerable animal welfare problems and financial losses in Norwegian sheep farming.

7 Jun 2010

Managing Myeloma launches MTR tool to help practitioners treat patients with multiple myeloma

Managing Myeloma is pleased to announce the launch of the Myeloma Treatment Resource at the annual American Society of Clinical Oncology meeting in Chicago. The MTR, developed by the Managing Myeloma multidisciplinary scientific advisors, is a compilation of convenient, unique tools and resources essential for practitioners treating patients with multiple myeloma.

7 Jun 2010

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine, June 5-9, in Salt Lake City.

7 Jun 2010

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

7 Jun 2010

Celldex Therapeutics reports mature data from CDX-011 Phase 1/2 study in advanced breast cancer

Celldex Therapeutics, Inc. today announced that mature results from a Phase 1/2 study evaluating CDX-011 in advanced stage breast cancer patients were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). CDX-011 is an experimental antibody-drug conjugate (ADC) directed against glycoprotein NMB (GPNMB) and linked to a potent cancer cell-killing drug, monomethyl-auristatin E (MMAE).

7 Jun 2010

New book highlights specific aspects of salivary gland development

Salivary glands are of utmost importance for several physiological functions ranging from the protection of teeth and surrounding soft tissues to the lubrication of the oral cavity, which is crucial for speech and perception of food taste.

5 Jun 2010

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

A recent retrospective study by four Michigan physicians shows strong evidence that symptoms of headache, dizziness and anxiety in some patients with traumatic brain injury potentially could be alleviated or even eliminated with specialized eyeglass lenses containing prisms.

5 Jun 2010

Maryland doctors to get rewards for cheaper care; In S.D., Sue to open more doc-owned hospitals

CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."

5 Jun 2010

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature for colorectal cancer. The clinical trial results showed a successful outcome that enables patients diagnosed with UICC stage II or UICC stage III colorectal cancer and with a high risk of disease progression to be identified and treated more appropriately.

5 Jun 2010

Masimo SET pulse oximetry screening effective for early diagnosis of critical CHD in newborns

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).

4 Jun 2010

Researchers generate the first comprehensive genetic parts list of mouse hypothalamus

A Johns Hopkins and Japanese research team has generated the first comprehensive genetic "parts" list of a mouse hypothalamus, an enigmatic region of the brain — roughly cherry-sized, in humans — that controls hunger, thirst, fatigue, body temperature, wake-sleep cycles and links the central nervous system to control of hormone levels.

4 Jun 2010

Strategy for harnessing physics for health

Following a workshop hosted by the CERN European particle physics laboratory in February, doctors and physicists today published a strategy for harnessing physics for health. Techniques developed for physics research have a long history of application in medicine. Today's news recognises that synergy, and sets out a programme of strengthened collaboration.

4 Jun 2010

Physicians and researchers to present 16 abstracts on cancer research at ASCO 2010

The John Theurer Cancer Center at Hackensack University Medical Center announced today that its physicians and researchers will present 16 abstracts on treatment and diagnostic progress in many different areas of oncology during the Annual Meeting of American Society of Clinical Oncology in Chicago, IL from June 4-8.

4 Jun 2010

Alere to introduce new global logo, brand identity at AHIP's Institute 2010

Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.

4 Jun 2010

EPIC Imaging Centers improves practice management services with MedInformatix RIS

As the largest and most technologically advanced outpatient imaging facility in the Portland metro area, EPIC Imaging Centers serves 120,000 patients a year with full-service MRI, PET/CT scanning, x-ray, ultrasound, mammography and other advanced imaging services. Always on the cutting edge, the company recently became home to the first stand-up MRI system in Oregon, providing thousands of patients with a more flexible option for achieving the most effective images to treat pain and other conditions.

4 Jun 2010

China Medical Technologies fourth-quarter revenues down 29.3% to $25.7 million

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced its unaudited financial results for the fourth fiscal quarter and the full fiscal year ended March 31, 2010.

4 Jun 2010

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines addressing ethnicity, gastrointestinal diseases and endoscopic procedures. The guideline suggests that colorectal cancer screening should begin at age 45 for average risk African-American men and women, and that it is recommended that colorectal cancer screening be emphasized for other minority ethnic groups that have lower screening utilization rates.

4 Jun 2010

BSGI effective for evaluating unclear mammographic or ultrasound findings

Researchers at the Legacy Good Samaritan Hospital in Portland, Oregon presented data on the clinical use of Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique, at the American Society of Breast Surgeons Annual meeting in Las Vegas in April: Breast Specific Gamma Imaging Used As An Adjunct to Mammography.

4 Jun 2010

Diagnostic News and Research

Celera applies CE mark to real-time PCR test for detection of variant in KIF6 gene

SCCT names finalists of fourth annual Young Investigator Award

Thesis examines infections caused by Anaplasma phagocytophilum in lambs

Managing Myeloma launches MTR tool to help practitioners treat patients with multiple myeloma

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

Celldex Therapeutics reports mature data from CDX-011 Phase 1/2 study in advanced breast cancer

New book highlights specific aspects of salivary gland development

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

Maryland doctors to get rewards for cheaper care; In S.D., Sue to open more doc-owned hospitals

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Masimo SET pulse oximetry screening effective for early diagnosis of critical CHD in newborns

Researchers generate the first comprehensive genetic parts list of mouse hypothalamus

Strategy for harnessing physics for health

Physicians and researchers to present 16 abstracts on cancer research at ASCO 2010

Alere to introduce new global logo, brand identity at AHIP's Institute 2010

EPIC Imaging Centers improves practice management services with MedInformatix RIS

China Medical Technologies fourth-quarter revenues down 29.3% to $25.7 million

ASGE issues guidelines on ethnicity, gastrointestinal diseases and endoscopic procedures

BSGI effective for evaluating unclear mammographic or ultrasound findings

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News